Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy VectivBio Holding stock | $6.4

Learn how to easily invest in VectivBio Holding stock.

VectivBio Holding AG is a biotechnology business based in the US. VectivBio Holding shares (VECT) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in VectivBio Holding

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VECT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

VectivBio Holding stock price (NASDAQ: VECT)

Use our graph to track the performance of VECT stocks over time.

VectivBio Holding shares at a glance

Information last updated 2021-10-25.
Latest market close$6.40
52-week range$5.90 - $37.70
50-day moving average $7.11
200-day moving average $11.14
Wall St. target price$25.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-6.24

Buy VectivBio Holding shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy VectivBio Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

VectivBio Holding price performance over time

Historical closes compared with the close of $6.4 from 2021-10-22

1 week (2021-10-19) 0.79%
1 month (2021-09-24) -16.88%
3 months (2021-07-26) -32.84%
6 months (2021-04-26) -60.00%
1 year (2020-10-22) N/A
2 years (2019-10-22) N/A
3 years (2018-10-22) N/A
5 years (2016-10-22) N/A

VectivBio Holding financials

Gross profit TTM $0
Return on assets TTM -59.78%
Return on equity TTM -288.88%
Profit margin 0%
Book value $2.62
Market capitalisation $227 million

TTM: trailing 12 months

Shorting VectivBio Holding shares

There are currently 116,084 VectivBio Holding shares held short by investors – that's known as VectivBio Holding's "short interest". This figure is 0.9% down from 117,088 last month.

There are a few different ways that this level of interest in shorting VectivBio Holding shares can be evaluated.

VectivBio Holding's "short interest ratio" (SIR)

VectivBio Holding's "short interest ratio" (SIR) is the quantity of VectivBio Holding shares currently shorted divided by the average quantity of VectivBio Holding shares traded daily (recently around 21299.816513761). VectivBio Holding's SIR currently stands at 5.45. In other words for every 100,000 VectivBio Holding shares traded daily on the market, roughly 5450 shares are currently held short.

To gain some more context, you can compare VectivBio Holding's short interest ratio against those of similar companies.

However VectivBio Holding's short interest can also be evaluated against the total number of VectivBio Holding shares, or, against the total number of tradable VectivBio Holding shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case VectivBio Holding's short interest could be expressed as 0% of the outstanding shares (for every 100,000 VectivBio Holding shares in existence, roughly 0 shares are currently held short) or 0.0049% of the tradable shares (for every 100,000 tradable VectivBio Holding shares, roughly 5 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against VectivBio Holding.

Find out more about how you can short VectivBio Holding stock.

VectivBio Holding share dividends

We're not expecting VectivBio Holding to pay a dividend over the next 12 months.

VectivBio Holding overview

VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for rare conditions. It develops Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as for SBS-IF in patients with colon-in-continuity anatomy. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. .

Frequently asked questions

What percentage of VectivBio Holding is owned by insiders or institutions?
Currently 8.883% of VectivBio Holding shares are held by insiders and 78.88% by institutions.
When does the fiscal year end for VectivBio Holding?
VectivBio Holding's fiscal year ends in December.
Where is VectivBio Holding based?
VectivBio Holding's address is: Aeschenvorstadt 36, Basel, Switzerland, 4051
What is VectivBio Holding's ISIN number?
VectivBio Holding's international securities identification number is: CH1109007893

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site